Edit |   |
---|---|
Antigenic Specificity | CD262, Human (Lexatumumab biosimilar) |
Clone | Lexatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD262 Recombinant Antibody (Lexatumumab). Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015. |
Immunogen | n/a |
Other Names | Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab, Anti-Human CD262 Recombinant Antibody(Lexatumumab), HGS-ETR2, Antibody Drug Analogues, Monoclonal Antibody, YR1118, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 845816-02-6 |
Catalog # | YR1118 |
Price | please inquire |
Order / More Info | CD262, Human (Lexatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |